Forlanini, Federica
Chan, Alice
Dara, Jasmeen
Dvorak, Christopher C.
Cowan, Morton J.
Puck, Jennifer M.
Dorsey, Morna J. http://orcid.org/0000-0002-9432-3542
Article History
Received: 1 April 2022
Accepted: 31 October 2022
First Online: 10 December 2022
Declarations
:
: This study was approved by the UCSF Institutional Review Board in accordance with the Declaration of Helsinki; participants were consented to the study; participants consented to their data being published.
: FF and JD have no conflict of interest. MJD has consulted for Horizon Therapeutics, and Chiesi Inc.t.; CCD has consulted for Alexion Inc. and Omeros Corporation and Jazz Pharmaceuticals; JMP is a writer and editor for UpToDate, and her spouse is employed by and owns stock in Invitae. MJC is a writer for UpToDate and is on advisory boards for bluebird bio, Homology Medicine Inc (owns stock), Chiesi Inc, and Rocket Pharma. AC has consulted for Invitae and Thymmune and Enzyvant.